Immunization with HIV protease peptides linked to syngeneic erythrocytes
Open Access
- 18 April 2007
- journal article
- Published by Springer Nature in Infectious Agents and Cancer
- Vol. 2 (1) , 9
Abstract
New potent vaccine adjuvants are desirable for increasing the efficacy of novel vaccine modalities such as DNA and peptides. We therefore tested if syngeneic erythrocytes could serve as delivery vectors for selected HIV peptides and compared the potency of these constructs to immunization with peptides in phosphate buffered saline or in incomplete Freunds adjuvant.Keywords
This publication has 12 references indexed in Scilit:
- Immunological cross-reactivity against a drug mutated HIV-1 protease epitope after DNA multi-CTL epitope construct immunizationVaccine, 2006
- Novel peptide-based HIV-1 immunotherapyExpert Opinion on Biological Therapy, 2004
- Immobilization of Enzymes and Proteins on Red Blood Cells2003
- Dual Pressure from Antiretroviral Therapy and Cell-Mediated Immune Response on the Human Immunodeficiency Virus Type 1 Protease GeneJournal of Virology, 2003
- Red blood cell-mediated delivery of recombinant HIV-1 Tat protein in mice induces anti-Tat neutralizing antibodies and CTLVaccine, 2003
- Phase I Trial of a Therapeutic HIV Type 1 Vaccine, Vacc-4x, in HIV Type 1-Infected Individuals with or without Antiretroviral TherapyAIDS Research and Human Retroviruses, 2002
- Lipopeptides induce cell-mediated anti-HIV immune responses in seronegative volunteersAIDS, 2001
- Red blood cells as delivery system for recombinant HSV-1 glycoprotein B: immunogenicity and protection in miceVaccine, 1997
- Preparation and characterization of biotinylated red blood cellsBiotechnology and Applied Biochemistry, 1994
- Red blood cells as an antigen‐delivery systemBiotechnology and Applied Biochemistry, 1992